![Author ORCID: We display the ORCID iD icon alongside authors names on our website to acknowledge that the ORCiD has been authenticated when entered by the user. To view the users ORCiD record click the icon. [opens in a new tab]](https://chemrxiv.org/engage/assets/public/chemrxiv/images/logos/orcid.png)
Abstract
A series of fluorescent coumarin bis-ureas have been synthesised and their anion transport properties studied. The compounds function as highly potent HCl co-transport agents in lipid bilayer membranes.
Coumarin-bisureas as potent fluorescent transmembrane anion transporters
07 October 2021, Version 1
Working Paper
This content is a preprint and has not undergone peer review at the time of posting.
Comments
Comments are not moderated before they are posted, but they can be removed
by the site moderators if they are found to be in contravention of our
Commenting Policy
[opens in a new tab]
- please read this policy before you post. Comments should be used for
scholarly discussion of the content in question. You can
find more information about how to use the commenting feature here
[opens in a new tab]
.
This site is protected by reCAPTCHA and the Google
Privacy Policy
[opens in a new tab]
and
Terms of Service
[opens in a new tab]
apply.
Now Published
A potent fluorescent transmembrane HCl transporter perturbs cellular pH and promotes cancer cell death [opens in a new tab]
Mohamed Fares, Xin Wu, Daniel A. McNaughton, Alexander M. Gilchrist, William Lewis, Paul A. Keller, Alain Arias-Betancur, Pere Fontova, Ricardo Pérez-Tomás, Philip A. Gale journal article
Organic & Biomolecular Chemistry
Online publication date: 2023
Version History
Oct 07, 2021 Version 1
Metrics
819
528
0
Views
Downloads
Citations
Funding
Australian Research Council
DP200100453
University of Wollongong
Postgraduate Awardand International Postgraduate Tuition Award scholarships
Author’s competing interest statement
The author(s) have declared they have no conflict of interest with regard
to this content
Ethics
The author(s) have declared ethics committee/IRB approval is not relevant
to this content